News & Updates
Showing Infectious Diseases articles
Showing
Show Multimedia Only

MTX treatment break improves COVID-19 booster response in patients with IMIDs
18 Aug 2022
byAudrey Abella
In individuals with immune-mediated inflammatory diseases (IMIDs*), a 2-week interruption in methotrexate (MTX) treatment led to enhanced COVID-19 booster vaccine response compared with those who continued with MTX treatment, according to findings from the VROOM** study.
18 Aug 2022







